Over the month of August, studies carried out in Israel, the UK and Qatar have proven that vaccines lose efficacy around four months after being administered. This fact has profound implications both in terms of pandemic monitoring and the economy. Thus, the chartbook we are publishing today features our reviewed stance on the achievement of herd immunity. We also distinguish between the efficacy of vaccines against infection and against hospitalisation and death, an analysis that leads us to determine potential effects on the economy.